Afamelanotide in Patients Suffering From Polymorphic Light Eruption (PLE)

Clinical trial NCT04704713 · COMPLETED

Trial details

NCT number: NCT04704713
Sponsor: Clinuvel Pharmaceuticals Limited
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Polymorphic Light Eruption

Start date: 2010-05-05
Primary completion: 2010-12-09
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.